ALFA Filings
Every announcement, straight from the exchange
Every Supha Pharmachem insolvency petition announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements with these filters
Supha Pharmachem disclosed an NCLAT order disposing of an insolvency appeal. The order prevents the Committee of Creditors from voting on resolutions until June 29, 2026.
NCLT approved Raju Mangilal Marshiya as Resolution Professional for Supha Pharmachem Limited. He replaces the erstwhile IRP, assuming control over the company's ongoing insolvency process.
Supha Pharmachem Limited announced outcomes of its first CoC meeting held on April 14, 2026. The CoC approved the appointment of Mr. Raju Mangilal Marshiya as Resolution Professional, replacing the interim professional. Other approved items include ratification of IRP remuneration, legal advisor fees, and the estimated six-month budget under the CIRP.
Supha Pharmachem Limited (formerly Remedium Lifecare) provided a CIRP update, disclosing total claims received of ₹123.75 Crore. An Interim Resolution Professional has been appointed by NCLT Mumbai, and the first Committee of Creditors meeting is scheduled for April 14, 2026. The company noted non-cooperation from suspended directors regarding records and control.